Back to Search
WENDELL YARBROUGH, MD
MD
Otolaryngology Physician
NPI: 1457448565IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
MD37330(TN)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 1989
Research & Publications (20)
Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
PMID 12975256·Circulation·2003
7-preclinical
Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
PMID 19577867·Int J Radiat Oncol Biol Phys·2010
8-other
Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation.
PMID 19626644·Head Neck·2010
8-other
Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.
PMID 18931703·Oncogene·2009
7-preclinical
Evolution of clinical trials in head and neck cancer.
PMID 18996026·Crit Rev Oncol Hematol·2009
6-review
Abdominal aortic aneurysm and significant coronary artery disease: strategies and options.
PMID 19088519·South Med J·2008
8-other
Microsatellite mutations in buccal cells are associated with aging and head and neck carcinoma.
PMID 18212747·Br J Cancer·2008
8-other
Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck.
PMID 18484593·Cancer·2008
3-trial
Antegrade and retrograde endoscopy for treatment of esophageal stricture.
PMID 18705567·Am Surg·2008
8-other
LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.
PMID 17785205·Cancer Cell·2007
7-preclinical
Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas.
PMID 17848307·Int J Radiat Oncol Biol Phys·2007
8-other
Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
PMID 17483334·Cancer Res·2007
8-other
Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.
PMID 16495760·J Cardiovasc Pharmacol·2006
4-observational
Alterations in cultured myocardial fibroblast function following the development of left ventricular failure.
PMID 16516916·J Mol Cell Cardiol·2006
7-preclinical
Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas.
PMID 16637057·Head Neck·2006
8-other
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
PMID 16912200·Cancer Res·2006
8-other
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
PMID 16943533·J Clin Oncol·2006
8-other
Mutagenic effect of cadmium on tetranucleotide repeats in human cells.
PMID 16989872·Mutat Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 35 PARK STREET, SMILOW CANCER HOSPITAL
NEW HAVEN, CT 06511 - Phone
- (203) 200-4622
Quick Facts
- NPI
- 1457448565
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile